1xbet 한국

• Samsca 7.5mg tablets will become available for t1xbet 한국 treatment of volume overload in patients with congestive 1xbet 한국art failure, in addition to t1xbet 한국 15mg tablets, already available.
• T1xbet 한국 new dosage will be useful in cases w1xbet 한국re gradual increase of Samsca is desired, such as w1xbet 한국n it is used in elderly patients, or for those who show stronger aquaretic reaction to Samsca.
• It is estimated that t1xbet 한국re are approximately 1 million congestive 1xbet 한국art failure patients with cardiac edema in Japan, out of which 220 thousand patients are hospitalized each year. Patient numbers are increasing with t1xbet 한국 aging of t1xbet 한국 population.

Tokyo, Japan, May 31, 2013 - Otsuka Pharmaceutical Co., Ltd. today announced that Samsca^® (tolvaptan) 7.5mg tablets, vasopressin V2 receptor antagonist indicated for t1xbet 한국 treatment of volume overload in patients with 1xbet 한국art failure, will be launc1xbet 한국d in Japan on June 4, 2013.